OLISENS 0

DRUG2 trials

Sponsors

University Of Cologne

Conditions

Corneal Neovascularization in Aniridia-associated KeratopathyPathologically prevascularized corneas due to herpetic keratopathy prior to “high-risk” corneal transplantation (keratoplasty)

Phase 2

Antisense Oligonucleotide Eye Drops Against IRS-1 to Treat Pathological Corneal Neovascularisation in Aniridia-Associated Keratopathy (Olisens-Aniridia)

Not yet recruitingCTIS2025-522609-39-00

University Of CologneCorneal Neovascularization in Aniridia-associated Keratopathy

Target: 20Updated: 2026-01-23

Antisense Oligonucleotide Eye Drops against IRS-1 to Optimize Pretransplant Lymphangio-regression Prior to High-Risk Keratoplasty (Olisens-Precon)

Not yet recruitingCTIS2025-522099-10-00

University Of ColognePathologically prevascularized corneas due to herpetic keratopathy prior to “high-risk” corneal transplantation (keratoplasty)

Target: 10Updated: 2026-01-28